Vilacto Bio, Inc. (VIBI)
|Net Income (ttm)||-7.52M|
|Trading Day||January 20|
|Day's Range||0.0000 - 0.0000|
|52-Week Range||0.0001 - 0.0014|
There are no news available yet.
Vilacto Bio operates as a biotech company in Denmark. The company holds a patented molecule license, known as the Lactoactive molecule for the treatment of inflammatory diseases, diabetics, psoriasis, and skin issues in various levels. It markets a line of skin care products, including lotions, skin care creams and gels, lip balms, foot creams and oils, and other items through its Website, vilacto.com. The company was formerly known as Zlato, Inc. and changed its name to Vilacto Bio Inc. in April 2017. Vilacto Bio Inc. was founded in 2013 and i... [Read more...]
|Stock Exchange |
|Ticker Symbol |
In 2018, Vilacto Bio's revenue was $4,894, an increase of 242.48% compared to the previous year's $1,429. Losses were -$6.85 million, 667.4% more than in 2017.